BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 23093699)

  • 1. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
    Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
    Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
    Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
    J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
    Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.
    Haven CJ; van Puijenbroek M; Tan MH; Teh BT; Fleuren GJ; van Wezel T; Morreau H
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):370-6. PubMed ID: 17555500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
    Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
    J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutation of the MEN1 gene in parathyroid tumours.
    Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
    Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
    Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
    J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
    Uchino S; Noguchi S; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Ohshima A; Futata T; Mizukoshi T; Koike E; Takatsu K; Terao K; Wakiya S; Nagatomo M; Adachi M
    Cancer Res; 2000 Oct; 60(19):5553-7. PubMed ID: 11034102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
    Grolmusz VK; Borka K; Kövesdi A; Németh K; Balogh K; Dékány C; Kiss A; Szentpéteri A; Sármán B; Somogyi A; Csajbók É; Valkusz Z; Tóth M; Igaz P; Rácz K; Patócs A
    Virchows Arch; 2017 Sep; 471(3):401-411. PubMed ID: 28597079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.
    Uchino S; Noguchi S; Nagatomo M; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Wakiya S; Adachi M
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():100s-103s. PubMed ID: 10915003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.